| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b8e2017b321a8b2a55f4c091d6b89c0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-23 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-23 |
| filingDate |
2020-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad91ece1a39be0ad6a985101aedeb01d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a79e855d808142a7a73a0b875e947f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_624a4efd39a3b0ca6251c629dde05438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9442bf4a71744fda0e7ad60837bab9d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6cde014c141aeafc6a426b8a1e65f9d |
| publicationDate |
2022-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2022177521-A1 |
| titleOfInvention |
Process for the preparation of degarelix |
| abstract |
The present invention provides a manufacturing process for the preparation of degarelix by using Fmoc protected amino acids as building blocks, wherein the Fmoc group is cleaved by treatment with tert-butylamine. |
| priorityDate |
2019-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |